Laura Deming is a pioneer in the field of longevity and health, and her efforts are making a significant impact. She is the founder of The Longevity Fund, a venture capital firm that invests in companies working to increase human lifespan and healthspan.
At just 25 years old, Laura Deming was already a seasoned investor, having started her first fund at age 15. She has a unique perspective on aging, having grown up watching her parents deal with the effects of aging.
Laura Deming's focus is on identifying and supporting companies that are working on innovative solutions to age-related diseases, such as cancer, Alzheimer's, and cardiovascular disease. By investing in these companies, she aims to accelerate the development of treatments that can improve human health and longevity.
Additional reading: Makes Laura Ashley Mattresses
Laura Deming's Focus
Laura Deming's focus is remarkable. At just 8 years old, she became fascinated by the biology of aging, which led her to join a lab at UCSF at age 12.
She successfully increased the lifespan of C. elegans worms by a factor of 10 through genetic engineering. This achievement showcases her exceptional intelligence and potential.
At 17, Deming dropped out of MIT and used $100,000 of Peter Thiel's money to start a longevity venture capital firm. This bold move demonstrates her confidence and drive.
Deming has been funding longevity companies for over a decade, and her recent open letter suggests that the field is at an inflection point.
Broaden your view: Wells Fargo Bank Deming New Mexico
Featured Images: pexels.com
